What sector does Repligen Corporation (RGEN) operate in?
Repligen Corporation belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Repligen Corporation (RGEN) current stock price?
As of the latest data, Repligen Corporation stock price is $113.11, with a previous close of $117.43. Repligen Corporation lost -$4.32 in the last trading session, representing a -3.68% loss.
What is Repligen Corporation (RGEN) current market capitalization?
Repligen Corporation market cap is approximately 6.38 billion.
What is Repligen Corporation (RGEN) Earnings Per Share (EPS)?
The trailing EPS is $0.86, and the forward EPS is $2.52.
What is Repligen Corporation (RGEN) Price-to-Earnings (P/E) ratio?
Repligen Corporation current P/E ratio is 131.52, with a forward P/E of 44.93.
What is Repligen Corporation (RGEN) EBITDA?
Repligen Corporation EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 44.98 million.
Does Repligen Corporation (RGEN) pay dividends?
No. Repligen Corporation does not pay a dividend.
How did Repligen Corporation (RGEN) perform in its most recent earnings report?
In the last report (December 31, 2025), Repligen Corporation posted an EPS surprise of 11.52% and a revenue surprise of -72.98%.
When is Repligen Corporation (RGEN) next earnings report?
Repligen Corporation is expected to release its next earnings report on March 31, 2026.
What is Repligen Corporation (RGEN) beta (volatility) score?
Repligen Corporation has a beta of 1.189, meaning its volatility is roughly in line with the market.